Trabeculectomy with mitomycin C supplemented with cross-linking hyaluronic acid: A pilot study;Erste Erfahrungen mit einem retikulierten Hyaluronsäurepräparat bei der Trabekulektomie

Klinische Monatsblatter fur Augenheilkunde

Volumn 227, Issue 4, 2010, Pages 273-276

  Sturmer J ^a   Mermoud, A ^b   Sunaricmegevand G ^c  

^a CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

^b Centre du Glaucoma   (Switzerland)

^c Augenarztpraxis ^*  (Switzerland)

Author keywords

Cross linking hyaluronic acid; Mitomycin C; Trabeculectomy

Indexed keywords

FLUOROURACIL; HYALURONIC ACID; MITOMYCIN C;

ADULT; AGED; ARGON LASER; ARTICLE; CONJUNCTIVA; FEMALE; FILTERING OPERATION; FOLLOW UP; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PILOT STUDY; PREOPERATIVE EVALUATION; PSEUDOEXFOLIATION; SCLERA; TRABECULECTOMY;

ADJUVANTS, IMMUNOLOGIC; AGED; ANTIBIOTICS, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; CROSS-LINKING REAGENTS; DRUG COMBINATIONS; DRUG SYNERGISM; EYE INFECTIONS; FEMALE; HUMANS; HYALURONIC ACID; MALE; MITOMYCIN; PILOT PROJECTS; TRABECULECTOMY; TREATMENT OUTCOME; WOUND HEALING;

EID: 77951555047     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1245186     Document Type: Article

References (12)

1. Araujo S V., Spaeth G L., Roth S M. et al. A ten-year follow-up on a prospective, randomized trial of postoperative corticosteroids after trabeculectomy. Ophthalmology 1995 102 1753-1759
2. Roth S M., Spaeth G L., Starita R J. et al. The effects of postoperative corticosteroids on trabeculectomy and the clinical course of glaucoma: five-year follow-up study. Ophthalmic Surg 1991 22 724-729
3. Cordeiro M F., Siriwardena D, Chang L et al. Wound healing modulation after glaucoma surgery. Current Opinion in Ophthalmol 2000 11 121-126 (Pubitemid 30164033)
4. Khaw P T. Advances in glaucoma surgery: evolution of antimetabolite adjunctive therapy. JGlaucoma 2001 10 (Suppl 1) S81-S84 (Pubitemid 33055188)
5. Lama P J., Fechtner R D. Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol 2003 48 314-346
6. Mead A L., Wong T T., Cordeiro M F. et al. Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery. Invest Ophthalmol Vis Sci 2003 44 3394-3401
7. Khaw P T., Grehn F, Hollo G et al. CAT-152 0102 Trabeculectomy Study Group. Ophthalmology 2007 114 1822-1830
8. Koz O G., Ozhuy S, Tezel G G. et al. The effect of paclitaxel on conjunctival wound healing: a pilot study. JGlaucoma 2007 16 610-615 (Pubitemid 350307613)
9. Forrester J V., Balazs E A. Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology 1980 40 435-446 (Pubitemid 10086557)
10. Anand N, Arora S, Clowes M. Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks. Br J Ophthalmol 2006 90 175-180 (Pubitemid 43163847)
11. Chang L, Thiagarajan M, Moseley M et al. Intraocular pressure outcome in primary 5FU phacotrabeculectomies compared with 5FU trabeculectomies. JGlaucoma 2006 15 475-481 (Pubitemid 44760319)
12. Reinthal E K., Denk P O., Grüb M et al. Dose, timing and frequency of subconjunctival 5-flurouracil injections after glaucoma filtering surgery. Graefes Arch Clin Exp Ophthalmol 2007 245 369-375 (Pubitemid 46403997)